Tekmira Pharmaceuticals Corp (TKM.TO)

TKM.TO on Toronto Stock Exchange

11.15CAD
11:12am EDT
Price Change (% chg)

$0.15 (+1.36%)
Prev Close
$11.00
Open
$11.27
Day's High
$11.27
Day's Low
$10.95
Volume
26,037
Avg. Vol
83,018
52-wk High
$34.66
52-wk Low
$4.97

TKM.TO

Chart for TKM.TO

About

Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing ribonucleic acid (RNA) interference (RNAi) therapeutics and providing its lipid nanoparticle (LNP) delivery technology to pharmaceutical partners. On March 1, 2012, it announced that the Company had secured a license from Alnylam to develop... (more)

Overall

Beta: 1.02
Market Cap (Mil.): $242.53
Shares Outstanding (Mil.): 22.07
Dividend: --
Yield (%): --

Financials

  TKM.TO Industry Sector
P/E (TTM): -- 106.71 36.40
EPS (TTM): -1.78 -- --
ROI: -37.91 0.13 18.27
ROE: -40.64 -0.64 19.15
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks